15 clinical trials matched your search for Skin Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Skin Cancer Study of RP1 in Organ Transplant Patients with Skin Cancer Shaheer Khan, DO
Melanoma CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma Benjamin Izar, MD
Melanoma Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease Alexander Wei, MD
Melanoma Study of DYP688 in Patients with Melanoma Alexander Wei, MD
Melanoma Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma Benjamin Izar, MD
Prostate Cancer Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer Mark Stein, MD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Pancreatic Cancer Chemo4METPANC: Combination of Chemotherapy, Motixafortide, and Cemiplimab in Patients with Pancreatic Cancer Gulam Manji, MD, PhD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Brain Tumors Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Brain Cancer Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Cancer Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors Karie D. Runcie, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of HRO761 Alone or in Combination with Tislelizumab or Irinotecan in Patients with Solid Tumors Edmond Chan, MD